Global ‘side effects’ of the EU’s pharmaceutical reforms and their impact on access to medicines in LMICs
Saved in:
| Main Author: | Katrina Perehudoff |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/10/4/e017789.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From Brussels to the World: The Diffusion of EU Pharmaceutical Legislation towards Developing Economies
by: S. Katrina Perehudoff
Published: (2025-06-01) -
The EU’s Precarious Old Normal and the Need for Reform
by: Hubert Gabrisch
Published: (2021-10-01) -
The EU’s Compensatory Power Amid Global Transactionalism
by: Goran Ilik, et al.
Published: (2025-03-01) -
The EU’s neoliberal constitutionalism(s)
by: Guillaume Grégoire
Published: (2024-12-01) -
Effects of the EU’s CBAM on Eurasian Countries
by: Sergei Sudakov
Published: (2023-12-01)